NEURITIN, A NEUROGENE - Patent 0920501

(19)

(11)

EP 0 920 501 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	17.11.2004 Bulletin 2004/47

(45)	Mention of the grant of the patent:
	29.10.2003 Bulletin 2003/44

(21)	Application number: 97935335.6

(22)	Date of filing: 07.08.1997

(51)	International Patent Classification (IPC)⁷: C12N 15/12, C07K 14/475, C07K 16/22

(86)	International application number:
	PCT/US1997/013949

(87)	International publication number:
	WO 1998/006843 (19.02.1998 Gazette 1998/07)

(54)	NEURITIN, A NEUROGENE NEURITIN, EIN NEUROGEN LA NEURITINE, UN NEUROGENE

(84)	Designated Contracting States:
	AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
	Designated Extension States:
	AL LT LV RO SI

(30)

Priority:

09.08.1996 US 694579

(43)	Date of publication of application:
	09.06.1999 Bulletin 1999/23

(60)	Divisional application:
	03010914.4 / 1361272

(73)	Proprietors:
	Amgen Inc., Thousand Oaks, California 91320-1799 (US) YEDA RESEARCH & DEVELOPMENT CO. LTD. 76100 Rehovot (IL)

(72)	Inventors:
	THEILL, Lars, Eyde Malibu, CA 90265 (US) NAEVE, Gregory, Scott Newbury Park, CA 91320 (US) CITRI, Yoav deceased (IL)

(74)	Representative: Grünecker, Kinkeldey, Stockmair & Schwanhäusser Anwaltssozietät
	Maximilianstrasse 58 80538 München 80538 München (DE)

(56)

References cited: :

EMBL/GENBANK DATABASES Accession no H34991 Sequence reference RS9913 XP002048084
N.LEE ET AL: "Comparative expressed-sequence-tag analysis of differential gene expression profiles in PC-12 cells before and after nerve growth factor treatment" PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, vol. 92, August 1995, WASHINGTON US, pages 8303-8307, XP002047703
EMBL/GENBANK DATABASES Accession no W57351 Sequence reference MM35124 M.MARRA ET AL: "The WashU-HHMI Mouse EST Project" XP002048085
EMBL/GENBANK DATABASES Accession no T08180 Sequence reference T08180 M.ADAMS ET AL: "Rapid cDNA sequencing from a directionally cloned human infant brain cDNA library" XP002048086
EMBL/GENBANK DATABASES Accession no Z41921 Sequence reference HSC03B061 C: AUFFRAY et al: "IMAGE: Integrated molecular analysis of the human genome and its expression" XP002048087
THEILL L E ET AL: "Novel genes induced in the hippocampal formation by glutamate analogs and-or neurotrophins." KEYSTONE SYMPOSIUM ON THE MOLECULAR AND CELLULAR BASIS OF HUMAN NEURODEGENERATIVE DISEASE, BRECKENRIDGE, COLORADO, USA, APRIL 3-9, 1995. JOURNAL OF CELLULAR BIOCHEMISTRY SUPPLEMENT 0 (21B). 1995. 95. ISSN: 0733-1959, XP002048080
E. NEDIVI ET AL: "Numerous candidate plasticity related genes revealed by differential cloning" NATURE, vol. 363, 24 June 1993, pages 718-722, XP002048081 cited in the application
GRUNWALD G B ET AL: "ISOLATION AND CHARACTERIZATION OF NEURITIN A NEURITE-ASSOCIATED CELL SURFACE MEMBRANE GLYCOPROTEIN OF THE RETINA." ANNUAL SPRING MEETING OF THE ASSOCIATION FOR RESEARCH IN VISION AND OPHTHALMOLOGY, SARASOTA, FLORIDA, USA, MAY 1-6, 1988. INVEST OPHTHALMOL VISUAL SCI 29 (ABSTR. ISSUE). 1988. 442. CODEN: IOVSDA ISSN: 0146-0404, XP002048082
NAEVE G S ET AL: "Neuritin: a gene induced by neural activity and neurotrophins that promotes neuritogenesis." PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, vol. 94, March 1997, WASHINGTON US, pages 2648-2653, XP002048083

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).